Effects of SARS-CoV-2 Variants on CD8+ T cell Epitope Diversity: Estimating Clinical Severity in the United States

Authors

Grace Kim, LSU Health Sciences Center - New OrleansFollow
Jacob Elnaggar, LSU Health Sciences Center - New OrleansFollow
Maya Sevalia, LSU Health Sciences Center - New OrleansFollow
Najah Nicholas, LSU Health Sciences Center - New Orleans
Mallory Varnado, LSU Health Sciences Center - New OrleansFollow
Judy Crabtree, LSU Health Sciences Center - New OrleansFollow
Lucio Miele, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

4-3-2024

Publication Title

Journal of Clinical and Translational Science

Abstract

Association for Clinical and Translational Science 2024; April 3 - April 5, 2024; Las Vegas, NV

First Page

95

Last Page

95

Volume

8

Comments

JCTS Abstract 309

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Kim, Grace; Elnaggar, Jacob; Sevalia, Maya; Nicholas, Najah; Varnado, Mallory; Crabtree, Judy; and Miele, Lucio, "Effects of SARS-CoV-2 Variants on CD8+ T cell Epitope Diversity: Estimating Clinical Severity in the United States" (2024). School of Medicine Faculty Publications. 3114.
https://digitalscholar.lsuhsc.edu/som_facpubs/3114
10.1017/cts.2024.280